洁特生物
(688026)
| 流通市值：29.77亿 | | | 总市值：29.77亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 277,457,045.28 | 107,856,760.78 | 563,976,836.75 | 398,180,432.24 |
| 营业总成本 | 257,287,868.6 | 113,800,338.52 | 485,139,596.82 | 340,567,157.86 |
| 其他经营收益 | | | | |
| 营业利润 | 23,975,011.82 | -2,921,191.54 | 62,361,607.53 | 65,915,672.38 |
| 利润总额 | 24,012,931.08 | -2,899,272.43 | 60,934,056.25 | 65,835,231.41 |
| 净利润 | 22,037,218.52 | -3,836,337.39 | 49,094,610.55 | 58,625,749.54 |
| 每股收益 | | | | |
| 其他综合收益 | -638,800.05 | -89,482.93 | 301,690.5 | 95,203.13 |
| 综合收益总额 | 21,398,418.47 | -3,925,820.32 | 49,396,301.05 | 58,720,952.67 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 791,580,892.95 | 785,535,438.45 | 809,533,876.63 | 791,796,976.25 |
| 非流动资产: | | | | |
| 非流动资产合计 | 941,391,632.38 | 930,833,692.35 | 931,794,222.14 | 956,429,320.25 |
| 资产总计 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 | 1,748,226,296.5 |
| 流动负债: | | | | |
| 流动负债合计 | 102,094,040.38 | 96,456,243.76 | 107,582,570.3 | 100,684,314.22 |
| 非流动负债: | | | | |
| 非流动负债合计 | 422,696,444.84 | 417,113,536.8 | 408,585,831.11 | 401,978,194.79 |
| 负债合计 | 524,790,485.22 | 513,569,780.56 | 516,168,401.41 | 502,662,509.01 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,195,735,347.86 | 1,192,546,446.14 | 1,216,301,466.2 | 1,237,119,448.66 |
| 股东权益合计 | 1,208,182,040.11 | 1,202,799,350.23 | 1,225,159,697.36 | 1,245,563,787.49 |
| 负债和股东权益合计 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 | 1,748,226,296.5 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 325,981,771.69 | 155,461,673.03 | 699,465,606.55 | 520,971,111.84 |
| 经营活动现金流出小计 | 290,877,488.71 | 134,190,509.95 | 507,705,964.72 | 392,674,512.47 |
| 经营活动产生的现金流量净额 | 35,104,282.98 | 21,271,163.08 | 191,759,641.83 | 128,296,599.37 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 634,433,591.48 | 356,065,600 | 1,016,847,151.26 | 637,696,783.2 |
| 投资活动现金流出小计 | 657,828,657.28 | 365,050,726.79 | 1,065,427,583.57 | 704,988,246.98 |
| 投资活动产生的现金流量净额 | -23,395,065.8 | -8,985,126.79 | -48,580,432.31 | -67,291,463.78 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,360,000 | - | 890,000 | - |
| 筹资活动现金流出小计 | 38,080,090.31 | 18,808,175.44 | 16,359,428.23 | 16,185,753.76 |
| 筹资活动产生的现金流量净额 | -36,720,090.31 | -18,808,175.44 | -15,469,428.23 | -16,185,753.76 |
| 汇率变动对现金及现金等价物的影响 | -9,336,091.65 | -4,843,367.34 | -2,154,555.92 | 1,858,451.38 |
| 现金及现金等价物净增加额 | -34,346,964.78 | -11,365,506.49 | 125,555,225.37 | 46,677,833.21 |
| 期末现金及现金等价物余额 | 209,603,537.97 | 232,584,996.26 | 243,950,502.75 | 165,073,110.59 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -34,346,964.78 | - | 125,555,225.37 | - |